Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [Phase 2]
Phase 2 clinical trial investigating combination chemotherapy with peripheral stem cell transplantation for stage III/IV ovarian epithelial …
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of CAR T cell therapy targeting mesothelin in metastatic cancer shows terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study evaluating PLX3397 in combination with pembrolizumab in advanced melanoma and other solid tumors was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer [Phase 3]
A Phase 3 trial comparing apatinib and etoposide capsule versus weekly paclitaxel in platinum-resistant ovarian cancer is ongoing (status un…
-
FDA approval · 2019-10-03FDA Approved: GEMCITABINE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for gemcitabine hydrochloride from Gland Pharma Limited. This approval enables the marketing of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial comparing standard infusion carboplatin to prophylactic extended infusion carboplatin in recurrent ovarian, fallopian tube, …
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating motolimod with doxorubicin and durvalumab in platinum-resistant recurrent ovarian cancer completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Engineered Immune Effectors Against Ovarian Cancer [Phase 1, Phase 2]
A clinical trial update on engineered immune effectors for ovarian cancer spanning Phase 1 and Phase 2.
-
FDA approval · 2019-09-13FDA Approved: MELPHALAN HYDROCHLORIDE — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved the original application for MELPHALAN HYDROCHLORIDE from Qilu Pharmaceutical Co., Ltd., granting approval of its generic produ…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191) [Phase 2]
Phase 2 trial update evaluating acalabrutinib alone and with pembrolizumab in ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours [Phase 1]
Phase I dose-escalation study of subcutaneous ALM201 in patients with advanced ovarian cancer and other solid tumors; study terminated with …
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Open Label Immunotherapy Trial for Ovarian Cancer [Phase 2]
Phase 2 open-label immunotherapy trial for ovarian cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) [Phase 2, Phase 3]
Clinical trial update on the efficacy of platinum-based chemotherapy in platinum-resistant ovarian cancer across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable [Phase 2]
Phase 2 study evaluating neoadjuvant bevacizumab (Avastin) in patients with initially unresectable FIGO stage IIIC/IV ovarian, tubal, or per…
-
FDA approval · 2019-08-12FDA Approved: DOXORUBICIN HYDROCHLORIDE LIPOSOME — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for doxorubicin hydrochloride liposome submitted by Baxter Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers [Phase 2]
Phase 2 trial update on weekly paclitaxel/carboplatin with Neupogen in gynecologic cancers (ovarian, endometrial, and cervical) has complete…
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. [Phase 3]
Phase 3 trial results for olaparib maintenance monotherapy in BRCA-mutated ovarian cancer after first-line platinum chemotherapy have been p…
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2a clinical trial update for DTA-H19 in advanced ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2019-06-10Clinical Trial Update: Ovarian Cancer Patient-Centered Decision Aid [NA]
A completed clinical trial evaluating a patient-centered decision aid for ovarian cancer care.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating low dose cyclophosphamide with or without nintedanib in advanced ovarian cancer and fallopian tube cancer has compl…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Study LY2228820 for Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for LY2228820 in recurrent ovarian cancer (epithelial ovarian cancer, fallopian tube cancer, primary perit…
-
FDA approval · 2019-05-28FDA Approved: MELPHALAN HYDROCHLORIDE — Original Application (Fosun Pharma USA Inc)
FDA approved the original application for melphalan hydrochloride (generic) supplied by Fosun Pharma USA Inc for use in treating multiple my…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours [Phase 2]
A Phase 2 clinical trial in BRCA-defective tumors including breast and ovarian cancer has completed recruitment and posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer [Phase 3]
A phase 3 randomized trial evaluating pelvic and aortic-cava lymphadenectomy for ovarian cancer has been suspended.